Th2/Th1 switch induced by a single low dose of cyclophosphamide in a rat metastatic lymphoma model.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 50, n. 11, p. 588, doi. 10.1007/s00262-001-0237-3
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2002 AND VI 50 AND IP 11
Results: 6
1
2
Anti-ErbB-2 monoclonal antibodies and ErbB-2-directed vaccines.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 50, n. 11, p. 569, doi. 10.1007/s002620100226
- By:
- Publication type:
- Article
3
Differential expression of granulysin and perforin by NK cells in cancer patients and correlation of impaired granulysin expression with progression of cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 50, n. 11, p. 604, doi. 10.1007/s002620100228
- By:
- Publication type:
- Article
4
The antimetastatic effect of a single low dose of cyclophosphamide involves modulation of galectin-1 and Bcl-2 expression.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 50, n. 11, p. 597, doi. 10.1007/s00262-001-0238-2
- By:
- Publication type:
- Article
5
Down-regulation of IL-2 receptor α (CD25) characterizes human γδ-T cells rendered resistant to apoptosis after CD2 engagement in the presence of IL-12.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 50, n. 11, p. 625, doi. 10.1007/s00262-001-0244-4
- By:
- Publication type:
- Article
6
HER-2/neu-derived peptide 884–899 is expressed by human breast, colorectal and pancreatic adenocarcinomas and is recognized by in-vitro-induced specific CD4<sup>+</sup> T cell clones.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 50, n. 11, p. 615, doi. 10.1007/s002620100225
- By:
- Publication type:
- Article